Palbociclib | High-Quality Pharmaceutical Reference Standard
Palbociclib is a selective CDK4/6 (cyclin-dependent kinase 4/6) inhibitor used in the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. It works by inhibiting CDK4/6 activity, preventing cell cycle progression and tumor growth. Palbociclib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including capsules.
Palbociclib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 14
